• Explore /
  • Poster
  • / Risk factors for neoadjuvant chemotherapy-induced acute kidney injury in patients with muscle-invasive bladder cancer: A multicenter retrospective study.

Risk factors for neoadjuvant chemotherapy-induced acute kidney injury in patients with muscle-invasive bladder cancer: A multicenter retrospective study.

Abstract Poster

Authors

null

Naoki Fujita

Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan

Naoki Fujita , Masaki Momota , Toshikazu Tanaka , Shogo Hosogoe , Shingo Hatakeyama , Takahiro Yoneyama , Yasuhiro Hashimoto , Chikara Ohyama

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Other

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 700)

DOI

10.1200/JCO.2024.42.4_suppl.700

Abstract #

700

Poster Bd #

L22

Abstract Disclosures

Similar Posters

First Author: Naoki Fujita

First Author: Amarnath Challapalli

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Docetaxel-based triplet neoadjuvant therapy for esophageal adenocarcinoma: A comprehensive analysis of outcomes spanning over a decade.

Docetaxel-based triplet neoadjuvant therapy for esophageal adenocarcinoma: A comprehensive analysis of outcomes spanning over a decade.

First Author: James Tankel

First Author: Nieves Martinez Chanza